SCHEMBL16627345

SCHEMBL16627345

CCCCOCC(OCCCC)C(CO)OCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.48
TSHR P16473 1/20 0.45
LPAR1 Q92633 5/20 0.40
LPAR3 Q9UBY5 5/20 0.40
LPAR2 Q9HBW0 2/20 0.40
HTT P42858 2/20 0.39
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
SPHK1 Q9NYA1 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
TLR2 O60603 1/20 0.35
PLA2G2C Q5R387 1/20 0.35
MGAM O43451 1/20 0.35
HSD17B10 Q99714 1/20 0.34
CYP3A4 P08684 1/20 0.34
LPAR6 P43657 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16638481 0.89 USP2 (0.46) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL5111690 0.88 TSHR (0.52) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL17792592 0.87 TSHR (0.44) USP2TSHRHTTMEN1THRB
SCHEMBL12137915 0.86 USP2 (0.41) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL13069406 0.86 USP2 (0.41) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL18081989 0.85 USP2 (0.40) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL14747652 0.85 USP2 (0.55) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL10990567 0.85 USP2 (0.55) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL13497241 0.85 TSHR (0.47) USP2TSHRLPAR1LPAR3LPAR2
SCHEMBL13843481 0.85 USP2 (0.50) USP2TSHRLPAR1LPAR3LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders THE GENERAL HOSPITAL CORPORATION 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders APP, PSEN1, PSEN2 USP2 3517/4885TSHR 4451/4885LPAR1 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.